沙特阿拉伯王国政府所属的官方政府网站。

周四 13 八月 2026

沙特官方政府网站的域名以下列后缀结尾 gov.sa

沙特阿拉伯王国所有政府机构的官方网站均以 .gov.sa 结尾。

Official Reliable websites use HTTPS

Ensure the website is using the HTTPS protocol.

在数字政府管理局注册,编号:

20250831619

建议

A phase III randomized open-label multi-center study of ruxolitinib vs. best available therapy in patients with corticosteroid-refractory acute graft vs. host disease after allogenic stem cell transplantation

A phase III randomized open-label multi-center study of ruxolitinib vs. best available therapy in patients with corticosteroid-refractory acute graft vs. host disease after allogenic stem cell transplantation

2022-06-27

عنوان الدراسة

A phase III randomized open-label multi-center study of ruxolitinib vs. best available therapy in patients with corticosteroid-refractory acute graft vs. host disease after allogenic stem cell transplantation

دواء الدراسة

Ruxolitinib (INC424) (Jakavi)

رقم بروتوكول الدراسة

CINC424C2301

حالة الدراسة

Completed

موقع الدراسة

KFSH&RC-R

مرحلة الدراسة

3